{"data":{"id":"us-ky/krs-218a.517","jurisdiction":"us-ky","citation":"KRS 218A.517","heading":"Drug developer to report quarterly to department -- Department to","body":"submit annual report to LRC.\n(1) The drug developer shall quarterly prepare and submit to the department a:\n(a) Report on the progress of any multistate drug development clini cal trials with\nibogaine conducted pursuant to KRS 218A.511 to 218A.519; and\n(b) Financial status report, including information to verify expenditures of\nCommonwealth funds and required matching funds.\n(2) The department shall submit an annual report by De cember 1 each year to the\nLegislative Research Commission for referral to the Interim Joint Committee on\nHealth Services on the progress of the drug development clinical trials and their\nrelated financial status until the clinical trials are concluded.","path":["KRS Chapter 218A"],"source_url":"https://apps.legislature.ky.gov/law/statutes/statute.aspx?id=57907","current_through":"Includes enactments through the 2026 Regular Session","vintage":"09/05/2026","retrieved_at":"2026-09-05T20:52:31Z","sha256":"a12fc77aee4925391a45fbd88ceae4056474f1a68f23cbafb5ba452731e52dff","source_id":"us-ky","stale":false,"prev":"us-ky/krs-218a.515","next":"us-ky/krs-218a.519"},"notice":"GroundRules: Original legal text. Not legal advice."}